HRT Financial’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,423
Closed -$149K 3224
2023
Q3
$149K Sell
18,423
-9,579
-34% -$78.3K ﹤0.01% 1898
2023
Q2
$211K Buy
28,002
+16,233
+138% +$124K ﹤0.01% 1818
2023
Q1
$94K Buy
+11,769
New +$121K ﹤0.01% 2070
2022
Q3
Sell
-56,875
Closed -$566K 3645
2022
Q2
$566K Buy
+56,875
New +$573K 0.01% 1397
2022
Q1
Sell
-14,509
Closed -$183K 4031
2021
Q4
$183K Buy
+14,509
New +$189K ﹤0.01% 2562

Other funds holding PTVE

HRT Financial's PTVE Position: Q4 2023 in Review

HRT Financial sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2023, closing a stake of 18,423 shares — an estimated $149K sold.

HRT Financial first reported a position in PTVE in Q4 2021 and held it in 5 quarters. The position peaked at $566K in Q2 2022. 127 funds tracked by Wall St. Rank hold PTVE as of Q4 2023.

  • HRT Financial reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 18,423 Pactiv Evergreen Inc. Common stock shares in Q4 2023, an estimated $149K.
  • HRT Financial first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Pactiv Evergreen Inc. Common stock position peaked at $566K in Q2 2022.
  • 127 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.